期刊文献+

抑郁症治疗药物发展 被引量:17

The progress of antidepressants
下载PDF
导出
摘要 抑郁症是一种常见的精神疾病,危害严重。随着对抑郁症发病机制研究的深入,抑郁症治疗药物快速发展,目前已取代了传统心理治疗而居主导地位。本文就抑郁症治疗药物现状和发展作一综述。 Depression is a common psychological disorder,which seriously impairs people's daily life.With the increasing understanding of pathogenesis of depression,the studies on medicines for the treatment of depression have been progressing rapidly.Currently,medical therapy has been playing a key role in the treatment of depression instead of conventional psychotherapy.This article reviews the progress in medications of depression.
出处 《上海医药》 CAS 2011年第6期267-269,共3页 Shanghai Medical & Pharmaceutical Journal
关键词 抑郁症 选择性5-羟色胺再摄取抑制剂 单胺氧化酶抑制剂 depression selective 5-hydroxytryptamine reuptake inhibitor monoamine oxidase inhibitor
  • 相关文献

参考文献12

  • 1张维熙,李淑然,陈昌惠,黄悦勤,王金荣,王德平,涂健,宁佐喜,付力牧,纪丽萍,刘志广,吴化民,罗开林,翟书涛,严和,孟国荣.中国七个地区精神疾病流行病学调查[J].中华精神科杂志,1998,31(2):69-71. 被引量:342
  • 2March JS,Silva S,Petrycki S,et al.The Treatment for Adolescents with Depression Study (TADS):Long-term effectiveness and safety outcomes[J].Arch Gen Psychiatry,2007,64(10):1132-1143.
  • 3von Knorring AL,Olsson GI,Thomsen PH,et al.A randomized,double-blind,placebo-controlled study of citalopram in adolescents with major depressive disorder[J].J Clin Psychopharmacol,2006,26(3):311-315.
  • 4Schirman S,Kronenberg S,Apter A,et al.Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents:An open-label study[J].J Neural Transm,2010,117(1):139-145.
  • 5Massana J.Reboxetine versus fluoxetine:An overview of efficacy and tolerability[J].J Clin Psychiatry,1998,59(Suppl 14):8-10.
  • 6Fang Y,Yuan C,Xu Y,et al.Comparisons of the efficacy and tolerability of extended-release venlafaxine,mirtazapine,and paroxetine in treatment-resistant depression:A double-blind,randomized pilot study in a Chinese population[J].J Clin Psychopharmacol,2010,30(4):357-364.
  • 7Mallinckrodt CH,Prakash A,Houston JP,et al.Differential antidepressant symptom efficacy:Placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine,paroxetine,escitalopram)[J].Neuropsychobiology,2007,56(2-3):73-85.
  • 8Papakostas GI,Nelson JC,Kasper S,et al.A meta-analysis of clinical trials comparing reboxetine,a norepinephrine reuptake inhibitor,with selective serotonin reuptake inhibitors for the treatment of major depressive disorder[J].Eur Neuropsychopharmacol,2008,18(2):122-127.
  • 9Sunderland T,Cohen RM,Molchan S,et al.High-dose selegiline in treatment-resistant older depressive patients[J].Arch Gen Psychiatry,1994,51(8):607-615.
  • 10Amsterdam JD,Bodkin JA.Selegiline transdermal system in the prevention of relapse of major depressive disorder:A 52-week,double-blind,placebo-substitution,parallel-group clinical trial[J].J Clin Psychopharmacol,2006,26(6):579-586.

二级参考文献6

  • 1团体著者,1993年精神疾病精神卫生服务和精神残疾调查资料汇编,1996年,13页
  • 2张明园,精神科评定量表手册,1993年,95页
  • 3杨德森,中国精神疾病诊断标准与案例,1989年,502页
  • 4沈渔--,精神病学(第2版),1988年,271页
  • 5团体著者,中华神经精神科杂志,1986年,19卷,65页
  • 6沈渔--,精神疾病流行学调查手册,1985年,11,42页

共引文献341

同被引文献175

引证文献17

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部